Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Neurology

Protecting the Brain: Symptoms and Neurological Risks

At a Glance

In Crigler-Najjar syndrome, high levels of unconjugated bilirubin can cross the blood-brain barrier and cause severe, permanent neurological damage known as kernicterus. Recognizing early warning signs like extreme lethargy or poor feeding is critical for immediate emergency intervention.

The most visible sign of Crigler-Najjar Syndrome (CNS) is jaundice, a deep yellowing of the skin and eyes caused by high bilirubin levels [1]. However, the primary focus of CNS management is protecting the brain. When unconjugated bilirubin levels rise too high, the bilirubin can become a “neurotoxin,” potentially leading to permanent neurological damage [2][3].

The Blood-Brain Barrier and Neurotoxicity

Bilirubin in CNS is unconjugated, meaning it is lipophilic (fat-soluble) [4]. Because it dissolves in fat, it can cross the blood-brain barrier, the protective shield that normally prevents harmful substances from reaching the brain [5].

Once inside the brain, bilirubin can cause:

  • ER Stress and Inflammation: It triggers inflammatory pathways (like NF-κB) that damage delicate nerve cells [2][6].
  • Cell Death (Apoptosis): High levels of bilirubin can cause brain cells to shut down and die [2].
  • Connectivity Issues: It can impair how new synapses (connections) form between neurons, affecting development [7].

Kernicterus and BIND

Doctors use two terms to describe bilirubin-related brain injury:

  1. BIND (Bilirubin-Induced Neurological Dysfunction): This refers to a spectrum of neurological issues that can range from subtle learning or movement problems to severe disability [8][6].
  2. Kernicterus: This is the most severe and permanent form of brain damage [3]. It typically affects specific areas of the brain, such as the globus pallidus (which controls movement) and the auditory pathway (which controls hearing) [9][10].

Early Warning Signs: What to Watch For

Neurological injury often begins with Acute Bilirubin Encephalopathy (ABE). Recognizing these signs early can allow for medical intervention before damage becomes permanent [11][12].

If you see any of the Phase 1 or 2 signs listed below, go to the nearest Emergency Room immediately and explicitly tell them your child has Crigler-Najjar Syndrome and is at risk for kernicterus.

Phase 1 (Immediate Warning):

  • Extreme Lethargy: The child is difficult to wake or unusually sleepy [13].
  • Poor Feeding: A sudden decrease in the ability to suck or swallow.
  • Changes in Muscle Tone: The child may seem unusually “floppy” (hypotonia) [14].

Phase 2 (Urgent Intervention Needed):

  • High-Pitched Cry: A distinctive, “shrill” cry that sounds different from their normal cry.
  • Stiffness or Arching: The child may arch their back or neck (opisthotonus) [12].
  • Irritability: Extreme fussiness that cannot be calmed.

Chronic Signs (Long-term Impact):

  • Movement Disorders: Involuntary muscle movements or dystonia [12][15].
  • Hearing Loss: Specifically sensorineural hearing loss, caused by damage to the auditory nerves [14][10].
  • Upward Gaze Palsy: Difficulty looking upward.

Why Spikes Happen: The “Stress” Factor

Even in Type II patients, who usually have lower bilirubin levels, certain situations can trigger a dangerous “spike” in bilirubin [16][17].

  • Illness and Infection: A fever or virus can increase the rate of red blood cell breakdown, flooding the liver with more bilirubin than it can handle [16].
  • Fasting or Dehydration: When a child doesn’t eat or drink enough, bilirubin levels can rise quickly.
  • Physical Stress: Surgery or significant injury can also lead to spikes.
  • Medication Contraindications: Certain common medications, such as ibuprofen and ceftriaxone, can displace bilirubin from albumin in the blood, increasing the risk of it crossing the blood-brain barrier [16]. Always consult your medical team before giving your child any new medications.

Monitoring with Advanced Imaging

In addition to regular blood tests, doctors may use MRI to look for signs of bilirubin impact. A specific technique called Diffusion Tensor Imaging (DTI) allows doctors to see microstructural changes in the brain’s white and gray matter before they might be visible on a standard scan [18][10]. Another tool, MR Spectroscopy (1H-MRS), can help measure the metabolic health of brain tissue [19]. These tools provide a “window” into the brain, helping your care team adjust treatments to ensure your child remains safe.

Common questions in this guide

What are the early warning signs of high bilirubin in Crigler-Najjar syndrome?
Early warning signs of a dangerous bilirubin spike include extreme lethargy, difficulty waking up, poor feeding, and a 'floppy' appearance. If you notice these symptoms, it is critical to seek emergency medical care immediately to prevent permanent brain injury.
What causes a sudden spike in bilirubin levels?
Bilirubin spikes can be triggered by common illnesses, fevers, viral infections, or dehydration. Fasting, physical stress like surgery, and certain medications like ibuprofen can also cause dangerous, rapid increases in unconjugated bilirubin.
What is kernicterus?
Kernicterus is a severe and permanent form of brain damage caused by extremely high levels of unconjugated bilirubin crossing the blood-brain barrier. It primarily affects areas of the brain that control movement and hearing.
Can doctors monitor my child's brain for early signs of damage?
Yes, doctors can use advanced MRI techniques like Diffusion Tensor Imaging (DTI) and MR Spectroscopy to look for early microstructural changes in the brain. These tools help your care team detect bilirubin impact before it becomes permanent and adjust treatments accordingly.
Why is unconjugated bilirubin dangerous to the brain?
Unconjugated bilirubin is fat-soluble, which allows it to cross the protective blood-brain barrier. Once inside the brain, it can act as a neurotoxin, triggering inflammation and causing delicate nerve cells to shut down and die.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is the specific bilirubin threshold for my child that should trigger an immediate ER visit?
  2. 2.Does our care team use the BIND (Bilirubin-Induced Neurological Dysfunction) score if we notice changes in my child’s behavior?
  3. 3.Should my child have a baseline MRI with DTI to monitor for microstructural changes in the brain?
  4. 4.How often should we schedule formal hearing tests and motor development evaluations?
  5. 5.What is the specific protocol for increasing phototherapy or administering IV fluids during a viral illness?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    Management of Crigler-Najjar syndrome.

    Tcaciuc E, Podurean M, Tcaciuc A

    Medicine and pharmacy reports 2021; (94(Suppl No 1)):S64-S67 doi:10.15386/mpr-2234.

    PMID: 34527915
  2. 2

    The pyroptosis mechanism of ototoxicity caused by unconjugated bilirubin in neonatal hyperbilirubinemia.

    Sun S, Yu S, Yu H, et al.

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023; (165()):115162 doi:10.1016/j.biopha.2023.115162.

    PMID: 37467648
  3. 3

    Disease burden of Crigler-Najjar syndrome: Systematic review and future perspectives.

    Dhawan A, Lawlor MW, Mazariegos GV, et al.

    Journal of gastroenterology and hepatology 2020; (35(4)):530-543 doi:10.1111/jgh.14853.

    PMID: 31495946
  4. 4

    Free Bilirubin Induces Neuro-Inflammation in an Induced Pluripotent Stem Cell-Derived Cortical Organoid Model of Crigler-Najjar Syndrome.

    Pranty AI, Wruck W, Adjaye J

    Cells 2023; (12(18)) doi:10.3390/cells12182277.

    PMID: 37759499
  5. 5

    Unconjugated bilirubin elevation impairs the function and expression of breast cancer resistance protein (BCRP) at the blood-brain barrier in bile duct-ligated rats.

    Xu P, Ling ZL, Zhang J, et al.

    Acta pharmacologica Sinica 2016; (37(8)):1129-40 doi:10.1038/aps.2016.25.

    PMID: 27180978
  6. 6

    [Impact of chaperone-mediated autophagy on bilirubin-induced damage of mouse microglial cells].

    Pan ZF, Li SY, Li L, et al.

    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2024; (26(4)):385-393 doi:10.7499/j.issn.1008-8830.2312014.

    PMID: 38660903
  7. 7

    Bilirubin impairs neuritogenesis and synaptogenesis in NSPCs by downregulating NMDAR-CREB-BDNF signaling.

    Zhang Y, Li S, Li L, et al.

    In vitro cellular & developmental biology. Animal 2024; (60(2)):161-171 doi:10.1007/s11626-023-00844-5.

    PMID: 38216855
  8. 8

    Prediction of 3- to 5-Month Outcomes from Signs of Acute Bilirubin Toxicity in Newborn Infants.

    El Houchi SZ, Iskander I, Gamaleldin R, et al.

    The Journal of pediatrics 2017; (183()):51-55.e1 doi:10.1016/j.jpeds.2016.12.079.

    PMID: 28131490
  9. 9

    Diagnostics Value of Quantitative Magnetic Resonance Imaging (MRI) in Neonatal Acute Bilirubin Encephalopathy.

    Liu H, Zhang R, Zhang M, et al.

    Journal of child neurology 2023; (38(3-4)):153-160 doi:10.1177/08830738231168514.

    PMID: 37063047
  10. 10

    Diffusion Tensor Imaging of Auditory Pathway in Patients With Crigler-Najjar Syndrome Type I: Correlation With Auditory Brainstem Response.

    Razek AAKA, Regal MEE, El-Shabrawi M, et al.

    Journal of child neurology 2022; (37(2)):119-126 doi:10.1177/08830738211025865.

    PMID: 34961382
  11. 11

    Bilirubin Encephalopathy.

    Qian S, Kumar P, Testai FD

    Current neurology and neuroscience reports 2022; (22(7)):343-353 doi:10.1007/s11910-022-01204-8.

    PMID: 35588044
  12. 12

    Childhood neurodevelopmental outcomes of survivors of acute bilirubin encephalopathy: A retrospective cohort study.

    Kumar V, Kumar P, Sundaram V, et al.

    Early human development 2021; (158()):105380 doi:10.1016/j.earlhumdev.2021.105380.

    PMID: 33990043
  13. 13

    BIND score: A system to triage infants readmitted for extreme hyperbilirubinemia.

    Hameed NN, Hussein MA

    Seminars in perinatology 2021; (45(1)):151354 doi:10.1016/j.semperi.2020.151354.

    PMID: 33309176
  14. 14

    Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation.

    Kemper AR, Newman TB, Slaughter JL, et al.

    Pediatrics 2022; (150(3)) doi:10.1542/peds.2022-058859.

    PMID: 35927462
  15. 15

    Case study on the use of intensive pediatric neurorehabilitation in the treatment of kernicterus.

    Mann J, Wallace DA, DeLuca S

    Journal of clinical movement disorders 2020; (7()):1 doi:10.1186/s40734-020-0084-z.

    PMID: 32042435
  16. 16

    UGT1A1-related Bilirubin Encephalopathy/Kernicterus in Adults.

    Bai J, Li L, Liu H, et al.

    Journal of clinical and translational hepatology 2021; (9(2)):180-186 doi:10.14218/JCTH.2020.00108.

    PMID: 34007799
  17. 17

    Spectrum of UGT1A1 variants in Pakistani children affected with inherited unconjugated hyperbilirubinemias.

    Zubaida B, Cheema HA, Hashmi MA, Naeem M

    Clinical biochemistry 2019; (69()):30-35 doi:10.1016/j.clinbiochem.2019.05.012.

    PMID: 31145902
  18. 18

    Diffusion Tensor Imaging of Microstructural Changes in the Gray and White Matter in Patients With Crigler-Najjar Syndrome Type I.

    Razek AAKA, Taman SE, El Regal ME, et al.

    Journal of computer assisted tomography 2020; (44(3)):393-398 doi:10.1097/RCT.0000000000001008.

    PMID: 32217895
  19. 19

    The added value of brain MR spectroscopy in children with Crigler-Najjar syndrome type-I: correlation with demographic, neurodevelopmental, and laboratory findings.

    Alnaghy E, Taman S, Abdelhalim E, et al.

    The British journal of radiology 2023; (96(1144)):20220433 doi:10.1259/bjr.20220433.

    PMID: 36809151

This page provides educational information on neurological risks associated with Crigler-Najjar syndrome. Always consult your medical team immediately if you suspect a bilirubin spike or notice changes in your child's behavior.

Get notified when new evidence is published on Crigler-Najjar syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.